: #PeptideTherapeutics #Biopharma #DrugDiscovery #PharmaceuticalInnovation #PeptideDrugs #TargetedTherapies #Biotechnology #HealthcareInnovation #OncologyResearch #Immunotherapy #ChronicDiseaseTreatment #PeptideBasedMedicine To view or add a comment, sign in Potent peptide ligands for therapeutically relevant targets are regularly returned from screening trillion-member libraries of ribosomally synthesized peptides containing non-canonical amino acids and macrocyclic architectures
Most of these strategies focus on supporting your bodys basic needs during a period of rapid metabolic change
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial
The platform facilitates the connection between patient and provider but does not practice medicine and does not guarantee any individual will receive a prescription
If youve been following the news around medications like semaglutide (Ozempic, Wegovy) , tirzepatide (Mounjaro, Zepbound) , and the newer retatrutide (still in clinical trials) , youve probably heard about their impressive results